Carbetocin versus oxytocin in the prevention of postpartum hemorrhage in cesarean section: a prospective randomised comparative study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20253880Keywords:
Carbetocin, Cesarean section, Oxytocin, Postpartum hemorrhage, UterotonicsAbstract
Background: Postpartum hemorrhage is the leading cause of maternal mortality. The prevention of PPH can be best done by active management of the third stage of labour. Oxytocin is currently the uterotonic of choice. The study compared the efficacy of Carbetocin 100 µg intravenous bolus and oxytocin 10 IU intravenous infusion over 2 hours by measuring total blood loss, the need for additional uterotonic agents, and the need for blood transfusion. It is important to evaluate the efficacy of Carbetocin compared to oxytocin in low-income countries, especially where patient affordability is a major concern.
Methods: A prospective randomised comparative single-blinded study was conducted in the department of obstetrics and gynecology, Kurji Holy Family Hospital, Patna, Bihar. 100 patients undergoing elective cesarean section fitting in the inclusion criteria were randomly allocated by a sealed envelope system to either case study group A receiving Carbetocin 100 µg intravenous and control study group B receiving oxytocin 10 IU intravenous infusion. Three specific outcomes were measured: total blood loss, additional uterotonic use and the need for blood transfusion.
Results: In this study, Carbetocin was found to significantly reduce total blood loss in comparison to oxytocin (p<0.0001), the use of additional uterotonics was significantly less in the Carbetocin group (p=0.023), the need for blood transfusion was less in Carbetocin group but not significantly (p=0.538).
Conclusions: Carbetocin has better efficacy in comparison to oxytocin in reducing total blood loss, hence preventing PPH. The need for additional uterotonic agents is less with Carbetocin use. The need for blood transfusion was also less with Carbetocin use but needs larger studies to be proved. Carbetocin may be cost-effective.
Metrics
References
World Health Organization, WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization, 2012.
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Global Health. 2014;2(6):e323-33. DOI: https://doi.org/10.1016/S2214-109X(14)70227-X
Shrivastava P, Lawrence S. Causes of maternal mortality rate: postpartum haemorrhage- a major cause in Madhya Pradesh. Int J Nurs Midwife Res. 2024;8(4)..
FOGSI. PPH Prevention and Management: Updated PPH Guidelines SEPTEMBER 2022. Federation of Obstetric and Gynaecological Societies of India. 2022. Available from: https://www.fogsi.org/wp-content/uploads/tog/pph-prevention-and-management-updated-sept-2022.pdf. Accessed on 21 June 2025.
Gülmezoglu AM, Widmer M, Merialdi M, Qureshi Z, Piaggio G, Elbourne D, et al. Active management of the third stage of labour without controlled cord traction: a randomized non-inferiority controlled trial. Reprod Health. 2009;6(1):2. DOI: https://doi.org/10.1186/1742-4755-6-2
Yermachenko A. The appraisal of the technical update “Prevention of postpartum haemorrhage by active management of third stage of labour” (2006). Paper presented at: Training Course in Sexual and Reproductive Health Research 2010. Geneva Foundation for Medical Education and Research; 2010. Available from: http://www.gfmer.ch/SRH-Course2010/assignments/Prevention-postpartum-haemorrhage-Yermachenko-2010.htm. Accessed 18 July 2025.
Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):15-20. DOI: https://doi.org/10.1016/j.ejogrb.2009.06.018
Widmer M, Piaggio G, Abdel-Aleem H, Carroli G, Chong YS, Coomarasamy A, et al. Room temperature stable carbetocin for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally: study protocol for a randomized controlled trial. Trials. 2016;17(1):143. DOI: https://doi.org/10.1186/s13063-016-1271-y
Engstrøm T, Barth T, Melin P, Vilhardt H. Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharmacol. 1998;355(2-3):203-10. DOI: https://doi.org/10.1016/S0014-2999(98)00513-5
Widmer M, Piaggio G, Nguyen TM, Osoti A, Owa OO, Misra S, et al. Heat-stable carbetocin versus oxytocin to prevent hemorrhage after vaginal birth. N Engl J Med. 2018;379(8):743-52. DOI: https://doi.org/10.1056/NEJMoa1805489
Tunçalp Ö, Souza JP, Gülmezoglu M. New WHO recommendations on prevention and treatment of postpartum hemorrhage. Int J Gynecol Obstet. 2013;123(3):254-6. DOI: https://doi.org/10.1016/j.ijgo.2013.06.024
Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet. 2009;280(5):707-12. DOI: https://doi.org/10.1007/s00404-009-0973-8
National Institute of Health and Care excellence. Cesarean birth NICE Guidelines. Available from: https://www.nice.org.uk/guidance/ng192/chapter/recommendations. Accessed on 17 October 2024.
Ibrahim ZM, Sayed Ahmed WA, Abd El-Hamid EM, Taha OT, Elbahie AM. Retracted article: Carbetocin versus oxytocin for prevention of postpartum hemorrhage in hypertensive women undergoing elective cesarean section. Hypertens Pregnancy. 2020;39(3):319-25. DOI: https://doi.org/10.1080/10641955.2020.1768268
Voon HY, Suharjono HN, Shafie AA, Bujang MA. Carbetocin versus oxytocin for the prevention of postpartum hemorrhage: a meta-analysis of randomized controlled trials in cesarean deliveries. Taiwanese J Obstet Gynecol. 2018;57(3):332-9. DOI: https://doi.org/10.1016/j.tjog.2018.04.002
Al Zubaidi S, Alhaidari T. Heat stable carbetocin versus. oxytocin for the prevention of post-partum hemorrhage in emergency cesarean delivery: a randomized controlled trial. J Perinat Med. 2022;50(2):150-6. DOI: https://doi.org/10.1515/jpm-2021-0206
Attilakos G, Psaroudakis D, Ash J, Buchanan R, Winter C, Donald F, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double‐blind randomised trial. BJOG. 2010;117(8):929-36. DOI: https://doi.org/10.1111/j.1471-0528.2010.02585.x
Maged AM, Hassan AM, Shehata NA. Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery in high risk women. J Matern Fet Neonat Med. 2016;29(4):532-6. DOI: https://doi.org/10.3109/14767058.2015.1011121
Downloads
Published
How to Cite
Issue
Section
